Evolve is gaining momentum as the CTMS and EDC solution of choice for the biopharma and CRO markets, as evidenced with the company’s recent announcement of year-to-date 500% increase in market product sales over Q2 2010. Key factors influencing the uptick in sales revenue include increased pressure within the life sciences market to reduce technology costs associated with eClinical solutions, groundbreaking advances in StudyManager’s products, growing market demand for eClinical solutions that are less cumbersome to implement, and increased awareness of StudyManager products among clinical trial sponsors and CROs.
"2011 has been somewhat of a watershed event for our company,” said Bruce D. Schatzman, CEO of StudyManager. “Not only has the growth been beyond our expectations, it has sustained itself and helps set the stage for breakout growth in the future.”
Evolve Enhances Efficiency and Boosts Productivity through Centralized Study Management
Evolve's web-based interface integrates clinical trial management and electronic data capture tools. These features are very scalable, and can be used together seamlessly or independently. Evolve enables users to create a single, centralized and secure location for key study information, simplifying study operations and enhancing team efficiency.
About StudyManager
StudyManager (also known as Advanced Clinical Software) is a privately held company focused exclusively on developing solutions for the clinical trial industry. Evolve, StudyManager’s set of study management tools for sponsors and CROs, has been successfully implemented by pharmaceutical, medical device, and biotech organizations, contract research organizations (CROs), and academic medical centers.
Contact:
Alec Fishburne
VP, Operations | StudyManager
206.957.7450 | alec@studymanager.com
